Literature DB >> 25841693

Integrative and complementary therapies for patients with advanced cancer.

Lucille Marchand1.   

Abstract

In integrative medicine, well-being is emphasized, and in palliative care, quality of life (QOL) is a similar concept or goal. Both can occur despite advanced cancer. Integrative medicine serves to combine the best of alternative, complementary and conventional therapies to optimize well-being and QOL, whether or not a person is at the end of their life. When integrative medicine is combined with palliative care modalities, the toolbox to provide symptom control and well-being or QOL is increased or broadened. Palliative care and integrative medicine are best provided early in the trajectory of illness such as cancer, and increase in amount as the illness progresses toward end of life. In cancer care, symptoms of the cancer, as well as symptoms produced by cancer therapies, are addressed with conventional and integrative therapies. Goals of care change as the disease progresses, and a patient's unique situation creates a different balance of integrative and conventional therapies. Integrative therapies such as music, aromatherapy, and massage might appeal to more patients than more specific, less common integrative therapies that might be more expensive, or seem more unusual such as Ayurvedic medicine and energy modalities. Each person may be drawn to different integrative modalities depending on factors such as cultural traditions, beliefs, lifestyle, internet information, advice from family and friends, books, etc. This review focuses on how integrative and complementary modalities can be included in comprehensive palliative care for patients with advanced malignancies. Nutrition and movement, often neglected in conventional treatment strategies, will also be included in the larger context of integrative and palliative modalities. Both conventional and integrative modalities in palliative care help patients live with empowerment, hope, and well-being no matter how long their lives last. A comprehensive review of all integrative and complementary therapies is impossible given the enormous diversity in this area. This review will concentrate on modalities such as nutrition, movement, music, aromatherapy, massage, select supplements, and acupuncture that have been researched in cancer survivors. Many of these modalities are quite effective for a number of symptoms in palliative care and have been studied in non-cancer populations. Resources for further study will also be included.

Entities:  

Keywords:  Integrative medicine; integrative cancer care; integrative oncology care; integrative palliative care; palliative care in oncology

Year:  2014        PMID: 25841693     DOI: 10.3978/j.issn.2224-5820.2014.07.01

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  5 in total

1.  Crossing the death threshold: experiencing multi-disciplinary end-of-life integrative oncology training.

Authors:  Eran Ben-Arye; Yael Keshet; Maria Livas; Thomas Breitkreuz
Journal:  Support Care Cancer       Date:  2018-02-01       Impact factor: 3.603

2.  Complementary and alternative medicine: attitudes, knowledge and use among surgeons and anaesthesiologists in Hungary.

Authors:  Sándor Árpád Soós; Norbert Jeszenői; Katalin Darvas; László Harsányi
Journal:  BMC Complement Altern Med       Date:  2016-11-08       Impact factor: 3.659

3.  Care of cancer patients with liver and bone metastases - the place of pharmaceutical care in a balanced plan, focused on the patient's needs and goals.

Authors:  Katarzyna A Rygiel; Mariola Drozd; Lucyna Bułaś
Journal:  Arch Med Sci       Date:  2016-06-13       Impact factor: 3.318

Review 4.  Essential Oils and Health.

Authors:  J Tyler Ramsey; B Carrie Shropshire; Tibor R Nagy; Kevin D Chambers; Yin Li; Kenneth S Korach
Journal:  Yale J Biol Med       Date:  2020-06-29

Review 5.  Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.

Authors:  S Franklyn De Silva; Jane Alcorn
Journal:  Pharmaceuticals (Basel)       Date:  2019-05-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.